Following the profit guidance released on 19 December 2017, the directors of Probiotec Limited announced that net profit before tax for the half year ended 31 December 2017 is now expected to be in the range of $1.5 million to $1.6 million. This represents an increase of 115% to 130% over the prior corresponding period and is approximately 10% above the upper range of guidance previously announced. Unaudited figures provided at a meeting of directors held on January 23, 2018 showed that trading in December had been stronger than expected, which has led to this upgrade. The directors remain confident in the previously advised full year outlook being, that in the absence of any significant deterioration in economic conditions, the Directors reasonably expect to deliver strong growth in both revenue and earnings in the 2018 financial year.